rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-4-21
|
pubmed:abstractText |
In Fabry disease, end-stage renal disease (ESRD) and severe neurologic and cardiac complications represent the leading causes of late morbidity and mortality. A comprehensive Italian nationwide survey study was conducted to explore changes in cardiac status and renal allograft function in Fabry patients on renal replacement therapy (RRT) and enzyme replacement therapy (ERT).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1460-2385
|
pubmed:author |
pubmed-author:BiancoFrancescoF,
pubmed-author:CagnoliLeonardoL,
pubmed-author:CianciarusoBrunoB,
pubmed-author:CioniAntonioA,
pubmed-author:ComottiCristinaC,
pubmed-author:CossuMariaM,
pubmed-author:FeriozziSandroS,
pubmed-author:FoschiAnnalisaA,
pubmed-author:GiudicissiAntonioA,
pubmed-author:GottiElianaE,
pubmed-author:LozuponeVito AntonioVA,
pubmed-author:MarchiniFrancescoF,
pubmed-author:MartinelliFabrizioF,
pubmed-author:MignaniRenzoR,
pubmed-author:PanichiVincenzoV,
pubmed-author:PisaniAntonioA,
pubmed-author:ProcacciniDeni AldoDA,
pubmed-author:RagazzoniElenaE,
pubmed-author:SerraAndreaA,
pubmed-author:SolianiFaustoF,
pubmed-author:SpinelliLetiziaL,
pubmed-author:TortiGiacomoG,
pubmed-author:VerouxMassimilianoM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1628-35
|
pubmed:meshHeading |
pubmed-meshheading:18057066-Adult,
pubmed-meshheading:18057066-Aged,
pubmed-meshheading:18057066-Cross-Sectional Studies,
pubmed-meshheading:18057066-Fabry Disease,
pubmed-meshheading:18057066-Female,
pubmed-meshheading:18057066-Humans,
pubmed-meshheading:18057066-Hypertrophy, Left Ventricular,
pubmed-meshheading:18057066-Isoenzymes,
pubmed-meshheading:18057066-Italy,
pubmed-meshheading:18057066-Kidney Failure, Chronic,
pubmed-meshheading:18057066-Kidney Transplantation,
pubmed-meshheading:18057066-Male,
pubmed-meshheading:18057066-Middle Aged,
pubmed-meshheading:18057066-Prospective Studies,
pubmed-meshheading:18057066-Recombinant Proteins,
pubmed-meshheading:18057066-Registries,
pubmed-meshheading:18057066-Renal Replacement Therapy,
pubmed-meshheading:18057066-Ventricular Dysfunction, Left,
pubmed-meshheading:18057066-alpha-Galactosidase
|
pubmed:year |
2008
|
pubmed:articleTitle |
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy.
|
pubmed:affiliation |
Department of Nephrology and Dialysis, Infermi Hospital, via Settembrini 2, 47900 Rimini, Italy. rmignani@auslrn.net
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|